- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 15, 2026 | 157.26M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 149.3M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 5.61M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$2.15M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$5.77M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$19.58M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$19.68M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $30.54M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $28.3M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $34.31M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $33.18M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $5.54M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $3.19M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $12.26M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $11.06M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.07 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$1.59 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.07 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$1.59 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $10.73M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $5.54M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$10.73M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$8.79M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$10.09M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$5.75M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $19.35M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $15.75M |
| Revenue | Q1 2026 · Mar 31, 2026 | $21.06M |
| Revenue | Q1 2026 · Mar 31, 2025 | $16.27M |